Moderna beats Pfizer to the punch, files EUA for Covid-19 vaccine for youngest children
Covid-19 vaccines for the youngest group of children (under the age of six) may soon be available — potentially in the next month — as Moderna announced on Thursday morning that it has submitted an EUA request to the FDA.
The FDA still needs to review the application, which is based on data unveiled late last month showing a robust neutralizing antibody response in the 6 month to under 6 years age group after a two-dose series of the vaccine, along with a favorable safety profile. The FDA still needs to set up an advisory committee of outside experts to review the data.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.